Sökning: WFRF:(van Oostenbrugge Robert) >
Effect of blood pre...
Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs) : a multicentre, open-label, randomised, crossover trial
-
- Kopczak, Anna (författare)
- University Hospital Munich
-
- Stringer, Michael S. (författare)
- University of Edinburgh
-
- van den Brink, Hilde (författare)
- University Medical Center Utrecht
-
visa fler...
-
- Kerkhofs, Danielle (författare)
- Yukioka Hospital
-
- Blair, Gordon W. (författare)
- University of Edinburgh
-
- van Dinther, Maud (författare)
- Yukioka Hospital
-
- Arteaga Reyes, Carmen (författare)
- University of Edinburgh
-
- Garcia, Daniela Jaime (författare)
- University of Edinburgh
-
- Onkenhout, Laurien (författare)
- University Medical Center Utrecht
-
- Wartolowska, Karolina A. (författare)
- University of Oxford
-
- Thrippleton, Michael J. (författare)
- University of Edinburgh
-
- Kampaite, Agniete (författare)
- University of Edinburgh
-
- Duering, Marco (författare)
- University of Basel,University Hospital Munich
-
- Staals, Julie (författare)
- Yukioka Hospital
-
- Lesnik-Oberstein, Saskia (författare)
- Leiden University Medical Centre
-
- Muir, Keith W. (författare)
- University of Glasgow
-
Middeke, Martin (författare)
-
- Norrving, Bo (författare)
- Lund University,Lunds universitet,Neurologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Klinisk strokeforskning,Forskargrupper vid Lunds universitet,Stroke policy och kvalitetsregisterforskning,Neurology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Clinical Stroke Research Group,Lund University Research Groups,Stroke policy and quality register research,Skåne University Hospital
-
- Bousser, Marie Germaine (författare)
- Université Paris Cité
-
- Mansmann, Ulrich (författare)
- Ludwig-Maximilian University of Munich
-
- Rothwell, Peter M. (författare)
- University of Oxford
-
- Doubal, Fergus N. (författare)
- University of Edinburgh
-
- van Oostenbrugge, Robert (författare)
- Yukioka Hospital
-
- Biessels, Geert Jan (författare)
- University Medical Center Utrecht
-
- Webb, Alastair J.S. (författare)
- University of Oxford
-
- Wardlaw, Joanna (författare)
- University of Edinburgh
-
- Dichgans, Martin (författare)
- German Center for Neurodegenerative Diseases (DZNE), Bonn,University Hospital Munich,Munich Cluster for Systems Neurology,German Centre for Cardiovascular Research
-
visa färre...
-
(creator_code:org_t)
-
- 2023
- 2023
- Engelska 14 s.
-
Ingår i: The Lancet Neurology. - 1474-4422. ; 22:11, s. 991-1004
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Hypertension is the leading risk factor for cerebral small vessel disease. We aimed to determine whether antihypertensive drug classes differentially affect microvascular function in people with small vessel disease. Methods: We did a multicentre, open-label, randomised crossover trial with blinded endpoint assessment at five specialist centres in Europe. We included participants aged 18 years or older with symptomatic sporadic small vessel disease or cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and an indication for antihypertensive treatment. Participants were randomly assigned (1:1:1) to one of three sequences of antihypertensive treatment using a computer-generated multiblock randomisation, stratified by study site and patient group. A 2-week washout period was followed by three 4-week periods of oral monotherapy with amlodipine, losartan, or atenolol at approved doses. The primary endpoint was change in cerebrovascular reactivity (CVR) determined by blood oxygen level-dependent MRI response to hypercapnic challenge in normal-appearing white matter from the end of washout to the end of each treatment period. Efficacy analyses were done by intention-to-treat principles in all randomly assigned participants who had at least one valid assessment for the primary endpoint, and analyses were done separately for participants with sporadic small vessel disease and CADASIL. This trial is registered at ClinicalTrials.gov, NCT03082014, and EudraCT, 2016-002920-10, and is terminated. Findings: Between Feb 22, 2018, and April 28, 2022, 75 participants with sporadic small vessel disease (mean age 64·9 years [SD 9·9]) and 26 with CADASIL (53·1 years [7·0]) were enrolled and randomly assigned to treatment. 79 participants (62 with sporadic small vessel disease and 17 with CADASIL) entered the primary efficacy analysis. Change in CVR did not differ between study drugs in participants with sporadic small vessel disease (mean change in CVR 1·8 × 10–4%/mm Hg [SE 20·1; 95% CI –37·6 to 41·2] for amlodipine; 16·7 × 10–4%/mm Hg [20·0; –22·3 to 55·8] for losartan; –7·1 × 10–4%/mm Hg [19·6; –45·5 to 31·1] for atenolol; poverall=0·39) but did differ in patients with CADASIL (15·7 × 10–4%/mm Hg [SE 27·5; 95% CI –38·3 to 69·7] for amlodipine; 19·4 × 10–4%/mm Hg [27·9; –35·3 to 74·2] for losartan; –23·9 × 10–4%/mm Hg [27·5; –77·7 to 30·0] for atenolol; poverall=0·019). In patients with CADASIL, pairwise comparisons showed that CVR improved with amlodipine compared with atenolol (–39·6 × 10–4%/mm Hg [95% CI –72·5 to –6·6; p=0·019) and with losartan compared with atenolol (–43·3 × 10–4%/mm Hg [–74·3 to –12·3]; p=0·0061). No deaths occurred. Two serious adverse events were recorded, one while taking amlodipine (diarrhoea with dehydration) and one while taking atenolol (fall with fracture), neither of which was related to study drug intake. Interpretation: 4 weeks of treatment with amlodipine, losartan, or atenolol did not differ in their effects on cerebrovascular reactivity in people with sporadic small vessel disease but did result in differential treatment effects in patients with CADASIL. Whether antihypertensive drug classes differentially affect clinical outcomes in people with small vessel diseases requires further research. Funding: EU Horizon 2020 programme.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Kopczak, Anna
-
Stringer, Michae ...
-
van den Brink, H ...
-
Kerkhofs, Daniel ...
-
Blair, Gordon W.
-
van Dinther, Mau ...
-
visa fler...
-
Arteaga Reyes, C ...
-
Garcia, Daniela ...
-
Onkenhout, Lauri ...
-
Wartolowska, Kar ...
-
Thrippleton, Mic ...
-
Kampaite, Agniet ...
-
Duering, Marco
-
Staals, Julie
-
Lesnik-Oberstein ...
-
Muir, Keith W.
-
Middeke, Martin
-
Norrving, Bo
-
Bousser, Marie G ...
-
Mansmann, Ulrich
-
Rothwell, Peter ...
-
Doubal, Fergus N ...
-
van Oostenbrugge ...
-
Biessels, Geert ...
-
Webb, Alastair J ...
-
Wardlaw, Joanna
-
Dichgans, Martin
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
The Lancet Neuro ...
- Av lärosätet
-
Lunds universitet